Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05484115 · ClinicalTrials.gov registry record · NA

Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck

A NA study of Aortic Aneurysm, Abdominal, sponsored by Rijnstate Hospital.

Recruiting
Registry status
NA
Development phase
300
Enrollment target
20
Study locations

NCT05484115: Recruiting NA study of Aortic Aneurysm, Abdominal, sponsored by Rijnstate Hospital.

NCT05484115 is a NA study of Aortic Aneurysm, Abdominal that is actively recruiting participants, run by Rijnstate Hospital. The registered enrollment target is 300 participants, above the 117-participant average among 8 other Aortic Aneurysm, Abdominal trials with a reported enrollment target (156% higher). The trial reports 20 study locations across 15 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05484115, a NA study of Aortic Aneurysm, Abdominal, is actively recruiting participants, sponsored by Rijnstate Hospital.

RECRUITING
Registry status
NA
Development phase
300 participants
Enrollment target
20
Study locations

Study Summary

The HERCULES trial is a Randomized controlled clinical trial designed to prospectively compare endosuture aneurysm repair (ESAR) to standard endovascular aneurysm repair (EVAR) clinical outcomes in treatment of infrarenal abdominal aortic aneurysm (AAA) in subjects having wide proximal aortic neck diameters (≥ 28mm and ≤ 32mm).

Primary Outcome

The primary endpoint is a composite endpoint based on core lab reported data from computed tomography (CT) with contrast imaging of freedom from: 1. type IA endoleak and 2. Migration of the proximal portion of the stent graft ≥5 mm (compared to 1-month imaging) and 3. Aneurysm sac growth ≥5 mm (compared to 1-month imaging).

Conditions Studied

Interventions

  • DEVICE endovascular aneurysm repair (EVAR) using the Endurant II/IIs stent graft system
  • DEVICE endosuture aneurysm repair (ESAR) using Heli-FX EndoAnchor system

Study Locations (20)

Other

  • HCL Lyon - Lyon
  • Saint Joseph Marseille - Marseille
  • Les Franciscaines - Nîmes

Michigan

  • Henry Ford Hospital - Detroit
  • Beaumont University Hospital - Royal Oak

Missouri

  • University of Missouri - Columbia
  • Barnes-Jewish Hospital - St Louis

New York

  • Sisters of Charity hospital - Buffalo
  • Stony Brook University Medical Center - Stony Brook

Arkansas

  • Washington Regional Medical Center - Washington

Florida

  • Mt Sinai Med Ctr - Miami Beach

Illinois

  • Loyola - Maywood

Minnesota

  • Alina Health - Minneapolis

Trial Details

FieldValue
Enrollment Target 300 participants
Start Date 2023-05-26
Est. Completion 2033-04
Phase NA
Rijnstate Hospital

1 total trials

What NCT05484115 shows while recruiting

NCT05484115 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 117-participant average among 8 other Aortic Aneurysm, Abdominal trials with a reported enrollment target (156% higher).

The record links to 1 condition, with Aortic Aneurysm, Abdominal appearing as the primary indexed condition, and to 2 interventions - of which endovascular aneurysm repair (EVAR) using the Endurant II/IIs stent graft system is the first listed.

NCT05484115 names 20 study sites across 15 states, led by Other, Michigan, Missouri.

Frequently Asked Questions

What is clinical trial NCT05484115 about?

NCT05484115 is a clinical study titled "Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck". The HERCULES trial is a Randomized controlled clinical trial designed to prospectively compare endosuture aneurysm repair (ESAR) to standard endovascular aneurysm repair (EVAR) clinical outcomes in treatment of infrarenal abdominal aortic aneurysm (AAA) in subjects having wide proximal aortic neck d...

What is the current status of trial NCT05484115?

This trial is currently recruiting. It is a NA study. The enrollment target is 300 participants. The study started on 2023-05-26. Estimated completion is 2033-04.

What conditions does trial NCT05484115 study?

This clinical trial studies the following conditions: Aortic Aneurysm, Abdominal.

What interventions are being tested in trial NCT05484115?

The interventions under investigation include: endovascular aneurysm repair (EVAR) using the Endurant II/IIs stent graft system (DEVICE), endosuture aneurysm repair (ESAR) using Heli-FX EndoAnchor system (DEVICE).

Who is sponsoring clinical trial NCT05484115?

This trial is sponsored by Rijnstate Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05484115 being conducted?

This trial has 20 study locations across Arkansas, Florida, Illinois, Michigan, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aortic Aneurysm, Abdominal

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05484115's enrollment target sits among peer trials

300 1st of 8 higher than 8 of 8 other Aortic Aneurysm, Abdominal trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aortic Aneurysm, Abdominal trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00353483 · 300 participants

    Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

  • NCT00588185 · 300 participants · NA

    [18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer

  • NCT00682032 · 300 participants · NA

    The Effect of Beta-glucan in Non-Small Cell Lung Cancer

  • NCT00870064 · 300 participants · NA

    The Treatment of Type I Open Fractures in Pediatrics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05484115, the US trial registry maintained by the National Library of Medicine. NCT05484115 (mid enrollment · wide site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.